Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NRXS
#4101
Neuraxis, Inc.
7.175
0
USD
+0.91%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.91%
Monthly Change
-0.97%
6 month change
+32.14%
Year Change
+32.14%
Previous Close
7.110
0
Open
7.290
0
Bid
Ask
Low
7.070
0
High
7.300
0
Volume
19
Markets
US Stock Market
Healthcare
NRXS
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2023
2024
2025
TTM
Key stats
Total common shares outstanding
6.59 M
7.22 M
11.19 M
—
Valuation ratios
Enterprise value
16.75 M
16.74 M
46.25 M
107.35 M
Price to earnings ratio
-0.56
-1.93
-4.78
-11.9
Price to sales ratio
3.36
6.05
11.55
29.82
Price to cash flow ratio
-1.23
-2.67
-6.41
-15.63
Price to book ratio
-5.89
7.88
12.14
16.04
Enterprise value to EBITDA ratio
-1.67
-2.52
-8.24
-15.81
Profitability ratios
Return on assets %
-28.71
-1.73
-1.22
-1.62
Return on equity %
10.42
-3.99
-2.29
-10.64
Return on invested capital %
-7 253.33
-4 413.58
-3 727.78
—
Gross margin %
87.67
86.52
84.23
336.73
Operating margin %
-270.91
-266.46
-219.37
-884.54
EBITDA margin %
-406.85
-247.13
-157.26
-896.28
Net margin %
-594.57
-306.84
-218.55
-881.59
Liquidity ratios
Quick ratio
0.12
1.74
1.96
7.47
Current ratio
0.13
1.75
2.05
7.67
Inventory turnover
14.3
11.05
3.73
7.04
Asset turnover
4.83
1.02
0.64
0.69
Solvency ratios
Debt to assets ratio
0.15
0.73
0.07
0.33
Debt to equity ratio
-0.05
1.68
0.12
1.93
Long term debt to total assets ratio
0
0.66
0.02
0.1
Long term debt to total equity ratio
0
1.53
0.04
0.48
Per share metrics
Operating cash flow per share
-2.06
-0.88
-0.71
-0.74
EBIT per share
-3.09
-0.96
-0.62
-0.96
EBITDA per share
-3.08
-0.96
-0.62
-0.95
Total debt per share
0.02
0.5
0.05
0.19
Cash per share
0.02
0.53
0.55
1.96
Net current asset value per share
0.07
0.62
0.63
2.25
Tangible book value per share
-0.46
0.28
0.34
1.06
Working capital per share
-0.51
0.26
0.32
1.07
Book value per share
-0.43
0.3
0.37
1.14
News
NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis
Top Stock Reports for Meta, Bank of America & Procter & Gamble
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
Neuraxis stock rises after FDA clearance for abdominal pain treatment
Neuraxis reports preliminary Q3 2025 financial results with $2.1 million operating loss
The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis
Top Research Reports for Alphabet, IBM & Merck
Neuraxis enters $3.3 million at-the-market equity offering agreement
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
Itaúsa 1H25 presentation: Record results and 10% net income growth amid portfolio strength
Craig-Hallum initiates NeurAxis stock with buy rating on pediatric device